Deborah J. Dehring
Research Subjects
Deborah J. Dehring has a total of 49 co-authors. Here are the top co-authors by number of shared publications:
Brian D. Lowery
4 shared publicationsCharles T. Cloutier
4 shared publicationsBeth L. Wismar
3 shared publicationsDaniel L. Traber
3 shared publicationsSteven M. Steinberg
3 shared publicationsDavid N. Herndon
2 shared publications
Latest Publications
- 1 February 2017
- Published by Wolters Kluwer Health in Anesthesia & Analgesia
- Vol. 124 (2) , 693
Preoperative Evaluation
- 1 February 2017
- Published by Wolters Kluwer Health in Anesthesia & Analgesia
- Vol. 124 (2) , 693
Preoperative Evaluation
- 1 November 2002
- Published by Wolters Kluwer Health in Anesthesiology
- Vol. 97 (5) , 1162-1167
Sulfite Supported Lipid Peroxidation in Propofol Emulsions
Background: Sodium metabisulfite is added to a commercial propofol emulsion as an antimicrobial agent. The sulfite ion (SO3(-2)) is capable of undergoing a number of reactions, including autooxidation and the promotion of lipid peroxidation. This study evaluated sulfite reactivity in propofol emulsions by determining thiobarbituric acid reacting substances (TBARS), sulfite depletion, and emulsion pH in emulsions containing sulfite or EDTA. Methods: Commercial EDTA and sulfite propofol emulsions were compared, and 10% soybean oil emulsion containing various additives were evaluated for TBARS, sulfite, and pH. TBARS were analyzed with a modified thiobarbituric acid method. Sulfite was analyzed by the reaction of sulfite with 5,5'-dithiobis(2-nitrobenzoic acid). pH was measured by glass electrode methodology. Results: Thiobarbituric acid reacting substances were detectable in commercial sulfite propofol emulsions in concentrations ranging from 0.02 to 0.22 microg/ml based on malondialdehyde. No TBARS were detected in EDTA propofol emulsions. Incubation (37 degrees C, up to 6 h) of sulfite propofol emulsions in air resulted in further increases in TBARS (35-160%). No increases occurred in incubated EDTA propofol emulsions. Metabisulfite (0.25 mg/ml) alone added to 10% soybean oil resulted in large increases in TBARS that were inhibited in part by propofol (10 mg/ml) and completely by ascorbic acid (0.05 mg/ml). Soybean oil emulsion pH declined rapidly on the addition of metabisulfite (0.25 mg/ml). The addition of propofol (10 mg/ml) partially inhibited the decline in pH and ascorbic acid (0.05 mg/ml) completely inhibited it. Conclusion: These results show that sulfite supports the peroxidation of lipids in soybean oil emulsions and propofol functions to partially inhibit these processes.
- 1 November 2002
- Published by Wolters Kluwer Health in Anesthesiology
- Vol. 97 (5) , 1162-1167
Sulfite Supported Lipid Peroxidation in Propofol Emulsions
Background: Sodium metabisulfite is added to a commercial propofol emulsion as an antimicrobial agent. The sulfite ion (SO3(-2)) is capable of undergoing a number of reactions, including autooxidation and the promotion of lipid peroxidation. This study evaluated sulfite reactivity in propofol emulsions by determining thiobarbituric acid reacting substances (TBARS), sulfite depletion, and emulsion pH in emulsions containing sulfite or EDTA. Methods: Commercial EDTA and sulfite propofol emulsions were compared, and 10% soybean oil emulsion containing various additives were evaluated for TBARS, sulfite, and pH. TBARS were analyzed with a modified thiobarbituric acid method. Sulfite was analyzed by the reaction of sulfite with 5,5'-dithiobis(2-nitrobenzoic acid). pH was measured by glass electrode methodology. Results: Thiobarbituric acid reacting substances were detectable in commercial sulfite propofol emulsions in concentrations ranging from 0.02 to 0.22 microg/ml based on malondialdehyde. No TBARS were detected in EDTA propofol emulsions. Incubation (37 degrees C, up to 6 h) of sulfite propofol emulsions in air resulted in further increases in TBARS (35-160%). No increases occurred in incubated EDTA propofol emulsions. Metabisulfite (0.25 mg/ml) alone added to 10% soybean oil resulted in large increases in TBARS that were inhibited in part by propofol (10 mg/ml) and completely by ascorbic acid (0.05 mg/ml). Soybean oil emulsion pH declined rapidly on the addition of metabisulfite (0.25 mg/ml). The addition of propofol (10 mg/ml) partially inhibited the decline in pH and ascorbic acid (0.05 mg/ml) completely inhibited it. Conclusion: These results show that sulfite supports the peroxidation of lipids in soybean oil emulsions and propofol functions to partially inhibit these processes.
- 1 June 1996
- Published by Wolters Kluwer Health in Shock
- Vol. 5 (6) , 440-445
DIFFERENTIAL EFFECTS OF PROLONGED SEPTICEMIA ON ISOLATED PULMONARY ARTERIES AND VEINS FROM SHEEP
Isolated third-order pulmonary arteries and veins from sheep were examined for the effects of septicemia on norepinephrine-induced contractions, nitric oxide (NO)-mediated dilation, and basal cyclic GMP levels. The groups studied were as follows: control sheep (n = 7); sheep given live Pseudomonas aeruginosa (Ps, n = 6) for 48 h; and sheep given NG-mono-methyl-L-arginine during the last 24 h of Ps infusion (PS-L-NMMA, n = 4). The norepinephrine-induced contractions were significantly greater (p < .05) in arteries from septic (Ps and PS-L-NMMA) sheep. Basal cyclic GMP levels were similar in all of the arteries. The norepinephrine-induced contractions were significantly depressed (p < .05) in veins from septic (Ps and PS-L-NMMA) sheep. Basal cyclic GMP levels in veins from Ps sheep were markedly elevated (p < .01). N$$-nitro-L-arginine methyl ester (L-NAME) ex vivo decreased cyclic GMP in both arteries and veins. Removal of endothelium enhanced contractions and decreased cyclic GMP in arteries and veins only from control sheep. The results show that septicemia differently affects the pulmonary artery and vein. The enhanced vasoconstriction of the artery is due to decreased endothelium-dependent NO release; the attenuated vasoconstriction of the vein is associated with NO-mediated increased cyclic GMP levels.
- 1 June 1996
- Published by Wolters Kluwer Health in Shock
- Vol. 5 (6) , 440-445
DIFFERENTIAL EFFECTS OF PROLONGED SEPTICEMIA ON ISOLATED PULMONARY ARTERIES AND VEINS FROM SHEEP
Isolated third-order pulmonary arteries and veins from sheep were examined for the effects of septicemia on norepinephrine-induced contractions, nitric oxide (NO)-mediated dilation, and basal cyclic GMP levels. The groups studied were as follows: control sheep (n = 7); sheep given live Pseudomonas aeruginosa (Ps, n = 6) for 48 h; and sheep given NG-mono-methyl-L-arginine during the last 24 h of Ps infusion (PS-L-NMMA, n = 4). The norepinephrine-induced contractions were significantly greater (p < .05) in arteries from septic (Ps and PS-L-NMMA) sheep. Basal cyclic GMP levels were similar in all of the arteries. The norepinephrine-induced contractions were significantly depressed (p < .05) in veins from septic (Ps and PS-L-NMMA) sheep. Basal cyclic GMP levels in veins from Ps sheep were markedly elevated (p < .01). N$$-nitro-L-arginine methyl ester (L-NAME) ex vivo decreased cyclic GMP in both arteries and veins. Removal of endothelium enhanced contractions and decreased cyclic GMP in arteries and veins only from control sheep. The results show that septicemia differently affects the pulmonary artery and vein. The enhanced vasoconstriction of the artery is due to decreased endothelium-dependent NO release; the attenuated vasoconstriction of the vein is associated with NO-mediated increased cyclic GMP levels.
- 5 October 1993
- Published by Elsevier in European Journal of Pharmacology
- Vol. 242 (3) , 255-261
Relaxation by calcitonin gene-related peptide may involve activation of K+ channels in the human uterine artery
- 5 October 1993
- Published by Elsevier in European Journal of Pharmacology
- Vol. 242 (3) , 255-261
Relaxation by calcitonin gene-related peptide may involve activation of K+ channels in the human uterine artery
- 1 June 1993
- Published by Wolters Kluwer Health in Critical Care Medicine
- Vol. 21 (6) , 888-893
Exaggerated cardiopulmonary response after bacteremia in sheep with week-old thermal injury
To determine if thermal injury impairs pulmonary intravascular clearance of bacteria and therefore leads to exaggerated cardiopulmonary dysfunction in sheep, since endotoxin infusion has been previously shown to induce more severe pulmonary injury after thermal injury. Prospective, unblinded, randomized, controlled trial. Laboratory at a large university medical center. Chronically instrumented, anesthetized sheep received a 40% total body surface area, third-degree thermal injury. Live Pseudomonas aeruginosa (10(7) P. aeruginosa/min for 1 hr; n = 6) were infused 7 to 10 days after thermal injury. Similarly prepared noninjured sheep received the same pseudomonas infusion (n = 7) or saline (n = 7). Bacterial clearance, which measures phagocytosis by the pulmonary intravascular macrophages, was equally efficient in intact sheep and sheep with thermal injury. Pulmonary hypertension persisted for 18 hrs after thermal injury, compared with 8 hrs in noninjured sheep. Lung lymph flow significantly increased from 6 to 8 hrs in only the thermal injury group. Both bacteremic groups developed a hyperdynamic circulation from 6 to 8 hrs, but cardiac index was 1 to 1.5 L/min/m2 higher in thermally injured sheep. Total peripheral resistance index decreased significantly from 6 to 24 hrs in thermally injured sheep and from 6 to 12 hrs in intact bacteremic sheep. Mean arterial pressure of thermally injured sheep was increased at baseline and for the first 6 hrs compared with noninjured animals. Mean arterial pressure decreased from 6 to 24 hrs in sheep with thermal injury but did not change in intact bacteremic sheep. Bacterial clearance was not impaired by preceding thermal injury in sheep. Bacteremia in the presence of a preexisting thermal injury led to more persistent pulmonary hypertension and an exaggerated hyperdynamic circulation.
- 1 June 1993
- Published by Wolters Kluwer Health in Critical Care Medicine
- Vol. 21 (6) , 888-893
Exaggerated cardiopulmonary response after bacteremia in sheep with week-old thermal injury
To determine if thermal injury impairs pulmonary intravascular clearance of bacteria and therefore leads to exaggerated cardiopulmonary dysfunction in sheep, since endotoxin infusion has been previously shown to induce more severe pulmonary injury after thermal injury. Prospective, unblinded, randomized, controlled trial. Laboratory at a large university medical center. Chronically instrumented, anesthetized sheep received a 40% total body surface area, third-degree thermal injury. Live Pseudomonas aeruginosa (10(7) P. aeruginosa/min for 1 hr; n = 6) were infused 7 to 10 days after thermal injury. Similarly prepared noninjured sheep received the same pseudomonas infusion (n = 7) or saline (n = 7). Bacterial clearance, which measures phagocytosis by the pulmonary intravascular macrophages, was equally efficient in intact sheep and sheep with thermal injury. Pulmonary hypertension persisted for 18 hrs after thermal injury, compared with 8 hrs in noninjured sheep. Lung lymph flow significantly increased from 6 to 8 hrs in only the thermal injury group. Both bacteremic groups developed a hyperdynamic circulation from 6 to 8 hrs, but cardiac index was 1 to 1.5 L/min/m2 higher in thermally injured sheep. Total peripheral resistance index decreased significantly from 6 to 24 hrs in thermally injured sheep and from 6 to 12 hrs in intact bacteremic sheep. Mean arterial pressure of thermally injured sheep was increased at baseline and for the first 6 hrs compared with noninjured animals. Mean arterial pressure decreased from 6 to 24 hrs in sheep with thermal injury but did not change in intact bacteremic sheep. Bacterial clearance was not impaired by preceding thermal injury in sheep. Bacteremia in the presence of a preexisting thermal injury led to more persistent pulmonary hypertension and an exaggerated hyperdynamic circulation.
- 1 December 1992
- Published by Elsevier in Anesthesiology Clinics of North America
- Vol. 10 (4) , 869-904
Pulmonary Thromboembolism
- 1 December 1992
- Published by Elsevier in Anesthesiology Clinics of North America
- Vol. 10 (4) , 869-904
Pulmonary Thromboembolism
- 1 October 1991
- Published by Springer Nature in Canadian Journal of Anesthesia/Journal canadien d'anesthésie
- Vol. 38 (7) , 919-925
Postoperative opisthotonus and torticollis after fentanyl, enfiurane, and nitrous oxide
Most drug-induced extrapyramidal symptoms are due to blockade of dopaminergic receptors and are treated with anticholinergic drugs. We report a patient with severe postoperative extrapyramidal symptoms which responded to physostigmine and indicated a different aetiology. A young, healthy female outpatient developed severe extrapyramidal symptoms after an uneventful 50 min anaesthetic with thiopentone, fentanyl (100 μg), enflurane, and nitrous oxide. Although the trachea was not extubated until she obeyed commands, the patient developed opisthotonus, which resolved initially after treatment with thiopentone (40 mg), diazepam (5 mg), and diphenhydramine (50 mg). The opisthotonus recurred approximately 25 min later, in association with torticollis, obtundation, and periodic apnoea. A tentative diagnosis of central anticholinergic syndrome was proposed, and fentanyl was considered to have been responsible. Naloxone (0.4 mg) induced no improvement, but physostigmine (2 mg) reversed the dystonic symptoms and periodic apnoea and improved her mental status. The response to physostigmine may have been due specifically to increased levels of acetylcholine at the cholinergic receptors, or to a nonspecific analeptic effect. La plupart des symptômes extrapyramidaux reliés à l’usage de médicaments sont causés par un blocage des récepteurs dopaminergiques et répondent bien aux anticholinergiques. Nous avons observé en postopératoire desmanifestations extrapyramidales répondant à l’usage de physostigmine, ce qui trahit une étiologie différente. Suite à une anesthésie de 50 minutes au thiopental, fentanyl (100 μg), enflurane et protoxyde d’azote et la détubation de la trachée après retour de la conscience, une jeune femme présenta un opisthotonos. Quarante mg de thiopental, 5 mg de diazépam et 50 mg de diphenhydramine parvinrent à contrer l’opisthotonos qui réapparu 25 minutes plus tard associé cette fois à un torticolis, de la stupeur et des pauses respiratoires. Avec un diagnostic présomptif de syndrome anticholinergique central attribuable au fentanyl, on essaya sans résultat 0,4 mg de naloxone. Deux mg de physostigmine suffirent à faire disparaître la dystonie et les pauses respiratoires et à améliorer l’état de conscience de la patiente. Cette réponse à la physostigmine peut être attribuable à une augmentation la quantité d’acétylcholine sur les récepteurs cholinergiques ou à un effet analeptique non-spécifique.
- 1 October 1991
- Published by Springer Nature in Canadian Journal of Anesthesia/Journal canadien d'anesthésie
- Vol. 38 (7) , 919-925
Postoperative opisthotonus and torticollis after fentanyl, enfiurane, and nitrous oxide
Most drug-induced extrapyramidal symptoms are due to blockade of dopaminergic receptors and are treated with anticholinergic drugs. We report a patient with severe postoperative extrapyramidal symptoms which responded to physostigmine and indicated a different aetiology. A young, healthy female outpatient developed severe extrapyramidal symptoms after an uneventful 50 min anaesthetic with thiopentone, fentanyl (100 μg), enflurane, and nitrous oxide. Although the trachea was not extubated until she obeyed commands, the patient developed opisthotonus, which resolved initially after treatment with thiopentone (40 mg), diazepam (5 mg), and diphenhydramine (50 mg). The opisthotonus recurred approximately 25 min later, in association with torticollis, obtundation, and periodic apnoea. A tentative diagnosis of central anticholinergic syndrome was proposed, and fentanyl was considered to have been responsible. Naloxone (0.4 mg) induced no improvement, but physostigmine (2 mg) reversed the dystonic symptoms and periodic apnoea and improved her mental status. The response to physostigmine may have been due specifically to increased levels of acetylcholine at the cholinergic receptors, or to a nonspecific analeptic effect. La plupart des symptômes extrapyramidaux reliés à l’usage de médicaments sont causés par un blocage des récepteurs dopaminergiques et répondent bien aux anticholinergiques. Nous avons observé en postopératoire desmanifestations extrapyramidales répondant à l’usage de physostigmine, ce qui trahit une étiologie différente. Suite à une anesthésie de 50 minutes au thiopental, fentanyl (100 μg), enflurane et protoxyde d’azote et la détubation de la trachée après retour de la conscience, une jeune femme présenta un opisthotonos. Quarante mg de thiopental, 5 mg de diazépam et 50 mg de diphenhydramine parvinrent à contrer l’opisthotonos qui réapparu 25 minutes plus tard associé cette fois à un torticolis, de la stupeur et des pauses respiratoires. Avec un diagnostic présomptif de syndrome anticholinergique central attribuable au fentanyl, on essaya sans résultat 0,4 mg de naloxone. Deux mg de physostigmine suffirent à faire disparaître la dystonie et les pauses respiratoires et à améliorer l’état de conscience de la patiente. Cette réponse à la physostigmine peut être attribuable à une augmentation la quantité d’acétylcholine sur les récepteurs cholinergiques ou à un effet analeptique non-spécifique.
- 1 October 1990
- Published by Wolters Kluwer Health in Critical Care Medicine
- Vol. 18 (10) , 1191-2
Ketanserin in the Treatment of Pulmonary Hypertension After Valvular Surgery
An abstract is unavailable. This article is available as a PDF only.
- 1 October 1990
- Published by Wolters Kluwer Health in Critical Care Medicine
- Vol. 18 (10) , 1191-2
Ketanserin in the Treatment of Pulmonary Hypertension After Valvular Surgery
An abstract is unavailable. This article is available as a PDF only.
- 1 October 1990
- Published by Wolters Kluwer Health
- Vol. 30 (10) , 1246-1251
Hydroxyethyl Starch Pretreatment in Bacteremic Sheep
Live bacteria were infused in a chronic ovine lung lymph model to determine if a preceding infusion of the colloid, hydroxyethyl starch (HES), exaggerated the cardiopulmonary dysfunction or impaired removal of bacteria by macrophages in the pulmonary circulation. HES was infused (3 mL/kg/hr; n = 6) from 24 to 12 hr before the bacteria and decreased plasma protein content and increased pulmonary lymph to plasma protein concentration because of its oncotic properties. Ringer's lactate (2 mL/kg/hr) was given after stopping HES and also to the control group (n = 6). Infusion of live Ps. aeruginosa (2.5 x 10(8) Ps./min for approximately 30 min) induced equivalent pulmonary hypertension, increased pulmonary microvascular permeability, and cardiovascular depression in the two groups. The removal of bacteria in the lungs was not affected, indicating that this measurement of the function of the mononuclear phagocytic system was not impaired by the preceding HES.
- 1 October 1990
- Published by Wolters Kluwer Health
- Vol. 30 (10) , 1246-1251
Hydroxyethyl Starch Pretreatment in Bacteremic Sheep
Live bacteria were infused in a chronic ovine lung lymph model to determine if a preceding infusion of the colloid, hydroxyethyl starch (HES), exaggerated the cardiopulmonary dysfunction or impaired removal of bacteria by macrophages in the pulmonary circulation. HES was infused (3 mL/kg/hr; n = 6) from 24 to 12 hr before the bacteria and decreased plasma protein content and increased pulmonary lymph to plasma protein concentration because of its oncotic properties. Ringer's lactate (2 mL/kg/hr) was given after stopping HES and also to the control group (n = 6). Infusion of live Ps. aeruginosa (2.5 x 10(8) Ps./min for approximately 30 min) induced equivalent pulmonary hypertension, increased pulmonary microvascular permeability, and cardiovascular depression in the two groups. The removal of bacteria in the lungs was not affected, indicating that this measurement of the function of the mononuclear phagocytic system was not impaired by the preceding HES.
- Open Access
- 1 July 1990
- Published by Wolters Kluwer Health in Anesthesiology
- Vol. 73 (1) , 146-164
Pulmonary Thromboembolism
- 1 July 1990
- Published by Wolters Kluwer Health in Anesthesiology
- Vol. 73 (1) , 146-164
Open AccessPulmonary Thromboembolism